FDA sends 2nd noncompliance notice for company failing to post trial results as crackdown ramps up
The FDA is slowly but surely continuing its crackdown on drugmakers that fail to post their clinical trial results to a government database in a …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.